Maxillofacial manifestations of Langerhans cell histiocytosis: A clinical and therapeutic analysis of 10 patients

Oral Oncology

Volumn 39, Issue 7, 2003, Pages 687-694

  Eckardt, A ^a   Schultze, A ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Curettage; Langarhans cell histiocytosis; Mandible; Maxilla

Indexed keywords

ANTINEOPLASTIC AGENT;

ABT LETTERER SIWE DISEASE; ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; EOSINOPHILIC GRANULOMA; FEMALE; FOLLOW UP; HISTIOCYTOSIS; HISTIOCYTOSIS X; HUMAN; HUMAN TISSUE; LANGERHANS CELL; MALE; MANDIBLE; MAXILLA; MAXILLOFACIAL DISORDER; MOUTH LESION; PRIORITY JOURNAL; RADIOTHERAPY; RECURRENT DISEASE; RETROSPECTIVE STUDY;

EID: 0042202324     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(03)00080-0     Document Type: Article

References (42)

1. Nezelof C., Basset F., Rousseau M.F. Histiogenetic arguments for a Langerhans cell origin. Biomedicine. 18:1973;365-371.
2. Histiocytosis syndromes in the childhood. Lancet. 1:1987;208-209.
3. Kelly K.M., Pritchard J. Monoclonal antibody therapy in langerhans cell histiocytosis - feasible and reasonable? Br J Cancer. 70(23):1994;54-55.
4. Brenner M. Currnt status of gene transfer into hamatopoietic progenitor cells: application to langerhans cell histiocytosis. Br J Cancer. 70(23):1994;56-57.
5. Oelench M., Vestring T. Unklare Osteolyse des rechten Unterkiefers. Radiologe. 33:1993;597-599.
6. Steurer J., Furrer J., Rhyner K., Vetter W., Siegenthaler W. Histiocytosis X - Klinik und Verlauf bei fünf Patienten. Dtsch Med Wochenschr. 116:1991;1702-1709.
7. Schajowicz F. Eosinophilic granuloma. Schajowicz X. Tumors and tumor-like lesions of bone: pathology, radiology and treatment. 1994;552-566 Springer, Berlin Heidelberg\New York.
8. Stoll M., Freund M., Schmidt H., Deicher H., Riehm H., Poliwoda H., Link H. Allogeneic bone marrow transplantation for Langerhans' cell histiocytosis. Cancer. 66:1990;284-288.
9. Bhatia S. Nesbit ME, Egeler M, Buckley JD, Mertens A, Robison LL Epidemiologic study of Langerhans cell histiocytosis in children. J Pediatr. 130:1997;774-784.
10. Betts D.R., Leibundgut K.E., Feldges A., Plüss H.J., Niggli F.K. Cytogenetic abnormalities in Langerhans cell histiocytosis. Br J Cancer. 77:1998;552-555.
11. Wu W.S., McClain K.L. DNA polymorphisms and mutations of the tumor necrosis factor-alpha (TNF-alpha) promotor in Langerhans cell histiocytosis (LCH). J Interferon Cytokine Res. 17:1997;631-635.
12. Pinkus G.S., Lones M.A., Matsumura F., Yamashiro S., Said J.W., Pinkus J.L. Langerhans cell histiocytosis immunohistochemical expression of fascin, a dendritic caD marker. Am J Clin Pathol. 18:2002;335-343.
13. Burgener F.A. Die Röntgenmanifestation der disseminierten Histiocytosis X beim Erwachsenen. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 126:1977;466.
14. David R., Oria R.A., Kumar R., Singleton E.B., Lindell M.M., Shirkhoda A., Madewell J.E. Radiologic features of eosinophilic granuloma of bone. MR Am J Roentgenol. 153:1989;1021.
15. Favara B.E., Jaffe R. Pathology of Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1:1987;75.
16. Liebermann P.H., Steinmann R.M., Smith J., Garin-Chesa P., Urmacher C., Sperber M. Langerhans cell (eosinophilic) granulomatosis. A clinicopathologic study encompassing 50 years. Am. J. Surg. Pathol. 20:1996;519-552.
17. Chu T., Jaffe R. The normal Langerhans cell and the LCH cell. Br J Cancer. 23:1994;4-9.
18. Crone-Munzenbrock W., Brassow F. A comparison of radiographic and bone scan findings in histiocytosis X. Skelet Radiol. 9:1983;170.
19. Malpas J.S., Norton A.J. Langerhans cell histiocytosis in the adult. Med Pediatr Oncol. 27:1996;540-546.
20. Favara B.E. FellerAC Contemporary classification of histiocytic disorders. Med Pediatr Oncol. 29:1997;157-166.
21. Leikin S.L. lmmunobiology of histiocytosis X. Hematol Oncol Clin North Am. 1:1987;49-61.
22. Giona F., Caruso R., Testi A.M., Moleti M.L., Malagnino F., Martelli M., Ruco L., Giannetti G.P., Annibali S., Mandelli F. Langerhans' cell histiocytosis in adults. A clinical and therapeutic analysis of 11 patients from a single institution. Cancer. 80:1997;1786-1791.
23. Riviera-Luna R., Alter-Molchadsky N., Cardenas-Cardos R., Martinez-Guerra G. Langerhans cell histiocytosis in children under 2 years of age. Med Pediatr Oncol. 26:1996;334-343.
24. Lavin T.P., Osband M.E. Evaluating the role of therapy in histiocytosis-X. clinical studies, staging and scoring Hematol Oncol Clin North Am. 1:1987;35-47.
25. Libicher M. Roeren 1, Tröger Localized Langerhans' cell histiocytosis of bone. treatment and follow-up in children Pediatr Radiol. 25:1995;134-137.
26. McCowage G.B., Frush D.P., Kurtzberg J. Successful treatment of two children with Langerhans' cell histiocytosis with 2′-deoxycoformycin. J Pediatr Hematol Oncol. 18:1996;154-158.
27. Basade M.M., Nair C.N., Kurkure P.A., Pai S.K., Advani S.H. Etoposide in Langerhans cell histiocytosis in children. a preliminary experience Med Pediatr Oncol. 13:1996;159-162.
28. Gadner H., Heitger A., Grois N., Gatterer-Menz I., Ladisch S. Treatment strategy for disseminated Langerhans cell histiocytosis. Med Pediatr Oncol. 23:1994;72-80.
29. Ladisch S., Gadner H., Aric M., Broadbent V., Grois N. Jacobson A Komp D, Nicholson HS LCH-I. a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis Med Pediatr Oncol. 23:1994;107-110.
30. Starling K.A. Chemotherapy of histiocytosis. Am J Pediatr Hernatol Oncol. 3:1981;157-160.
31. Jones B., Kung F., Chevalier L. Chemotherapy of reticuloendotheliosis. Comparison of methotrexate plus prednisolone vs. vincristine plus prednisolone. Cancer. 34:1974;1011-1017.
32. Hirose M., Saito S., Yoshimoto T., Kuroda Y. Interleukin-2 therapy of Langerhans cell histiocytosis. Acta Paediatr. 84:1995;1204-1206.
33. Brenez D., Devriendt J., Lenclud C., Schmerber J. Acute nonlymphocytic leukemia following chemotherapy with cisplatin and etoposide for non-small-cell carcinoma of the lung. Cancer Chemother Pharmacol. 26:1990;235-236.
34. Haupt R., Comelli A., Rosanda C., Sessarego M., De Bernardi B. Acute myeloid leukemia after single-agent treatment with etoposide for Langerhans cell histiocytosis of bone. Am J Pediatr Hematol Oncol. 15:1993;255-257.
35. Hawkins M.M., Wilson L.M.K., Stovall M.A., Mardsen H.B., Potok M.H., Kingston J.E., Cessells J.M. Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukemia after childhood cancer. BMJ. 304:1992;951-958.
36. Komp D.M., Vietti T.J., Berry D.H. Combination therapy in histiocytosis x. Med Pediatr Oncol. 3:1977;267-273.
37. Lahey M.E. Histiocytosis X - comparison of three treatment regimens. J Pediatr. 87:1975;179-183.
38. Pedersen-Bjergaard J., Daugaard G., Hansen S.W., Philip P., Larson S.O., Rorth M. Increased risk of myelodysplasia and leukemia after etoposide, cisplatin and bleomycin for germ-cell tumors. Lancet. 338:1991;359-363.
39. Histiocytosis syndromes in the childhood. II. Approach to the clinical and laboratory evaluation of children with Langerhans cell histiocytosis Med Pediatr Oncol. 17:1989;492-495.
40. Hartman K.S. Histiocytosis X. a review of 114 cases with oral involvement Oral Surg Oral Med Oral Pathol. 49:1980;38-54.
41. Chomette G., Auriol M., Ragot J.P., Guilbert F. Histiocytosis X of the jaw. I. Anatomico-clinical study apropos of 61 cases. Rev Stomatol Chir Maxillofac. 88:1987;334-338.
42. Bartnick A., Friedrich R.E., Roeser K., Schmelzle R. Oral Langerhans cell histiocytosis. J Cranio Maxillofac Surg. 30:2002;91-96.